Loading clinical trials...
Loading clinical trials...
Pharmacokinetics and Pharmacodynamics of Calcitriol 3 mcg/g Ointment Applied Twice Daily for 14 Days Under Conditions of Maximal Use in Pediatric Subjects (2 to 12 Years of Age) With Plaque Psoriasis
Conditions
Interventions
Calcitriol 3 mcg/g ointment
Locations
8
United States
Rady Children's Hospital - Pediatric and Adolescent Dermatology
San Diego, California, United States
Dawes Fretzin Clinical Research Group, LLC
Indianapolis, Indiana, United States
University of Michigan Medical Center
Ann Arbor, Michigan, United States
University of North Carolina Dermatology and Skin Cancer Center
Chapel Hill, North Carolina, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Menter Dermatology Research Institute
Dallas, Texas, United States
Start Date
March 1, 2013
Primary Completion Date
November 1, 2015
Completion Date
November 1, 2015
Last Updated
February 18, 2021
NCT06979453
NCT07116967
NCT07250802
NCT07449702
NCT07290569
NCT06888193
Lead Sponsor
Galderma R&D
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions